The 2012 Bio International Convention
June 20, 2012
The 2012 BIO International Convention is being held from June 18 to 21 in Boston, Massachusetts, a region which now has the highest concentration of biotechnology researchers in the United States.
The BIO International Convention, whose 2012 theme is “Connect. Partner. Innovate” brings together major players in the biotechnology sector. With more than 15,000 participants from 65 countries, BIO offers a broad range of opportunities for meetings and discussions that may lead to new partnerships. Sanofi – the event’s double helix sponsor – will be in the Mass Pavilion and participate with Sanofi Pasteur and Genzyme in a dozen sessions.
Sanofi will be represented by its CEO, Christopher A. Viehbacher, by Elias Zerhouni, President Global R&D, and by David Meeker, President and CEO of Genzyme. Christopher A. Viehbacher will speak twice during the Convention to a panel of experts on the theme of Innovation in sessions entitled "Biotech and Big Pharma - What's next?” And “Pre-competitive collaboration: Innovation of the future?”.